Next-generation food technology company Arborea raises € 3.6 million funding round led by BGF
Arborea, which industrializes photosynthesis to expand the global food supply, has finalized a funding round led by investor BGF, alongside Rubio Impact Ventures and Volta Circle.
Arborea is a technology company that has developed a revolutionary culture platform for photosynthetic microorganisms for use as food ingredients and proteins. It was founded by CEO Julian Melchiorri in 2015 following his research at Imperial College London.
Global food security is a growing problem driven by population growth and climate change, exacerbated by slowing improvements in crop yields and decreasing availability of new agricultural land. Traditional agricultural practices will not be sufficient to adequately feed the world’s population by mid-century, and as a result, the need for new agricultural technologies that save land, water and energy becomes increasingly urgent.
Photosynthetic microorganisms are cultivated using Arborea’s Biosolar Leaf (BSL) technology, which provides a more productive and cost effective method for cultivation on an industrial scale than existing systems. The technology works by mimicking the mechanisms of a leaf to effectively maintain optimal growing conditions with minimal energy input. In addition, it is particularly well placed to separate CO2 of most exhaust gases at atmospheric pressure and low concentrations.
The € 3.6 million funding round will help the company develop its BSL technology at a demonstration facility in Portugal, which will be used to demonstrate the company’s ability to cultivate functional ingredients and high-quality proteins. Commercial grade value used in food and beverage (F&B) and nutraceutical applications.
Julian Melchiorri, CEO of Arborea, said: “We believe that photosynthetic microorganisms will be a key choice for the production of food ingredients and proteins due to their high productivity, versatility and low environmental impact. . Arborea has developed a technology that reinvents the way these microorganisms are cultivated, solving the critical bottlenecks of legacy technologies to finally unleash the untapped value of this vast, highly diverse microbiological pool for the good of our society and our planet. . With this funding, after developing the technology over the past 6 years and testing it at our pilot site in London, the team is now ready to move to a much larger operational demonstration facility, which will be used for develop technology and support the conversion of the commercial interest of level 1 F&B players ”.
Rowan Bird, investor at BGF, said: “Given the focus on the alternative protein sector, Arborea stands out with an attractive combination of early validation of its technology, encouraging discussions with partners and customers. potentials, and business-to-scale potential. Arborea represents an exciting opportunity for BGF to invest in an exciting new technology platform that will help solve one of the world’s most important systemic issues (food safety) while dramatically reducing the environmental impact of our protein supply chain. “